Detalhe da pesquisa
1.
Genomic origin, fragmentomics, and transcriptional properties of long cell-free DNA molecules in human plasma.
Genome Res
; 34(2): 189-200, 2024 Mar 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38408788
2.
Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs.
Proc Natl Acad Sci U S A
; 120(17): e2220982120, 2023 04 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37075072
3.
Innovations in RNA therapy for hemophilia.
Blood
; 142(19): 1613-1621, 2023 11 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37478403
4.
Epigenetic analysis of cell-free DNA by fragmentomic profiling.
Proc Natl Acad Sci U S A
; 119(44): e2209852119, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36288287
5.
Dual CTLA-4 and PD-1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first-in-human, dose-escalation, and dose-expansion study.
Cancer
; 130(11): 1991-2002, 2024 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38404184
6.
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment.
J Hepatol
; 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38570034
7.
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 401(10391): 1853-1865, 2023 06 03.
Artigo
Inglês
| MEDLINE | ID: mdl-37075781
8.
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Lancet
; 402(10408): 1133-1146, 2023 09 30.
Artigo
Inglês
| MEDLINE | ID: mdl-37499670
9.
A Liver Stiffness-Based Etiology-Independent Machine Learning Algorithm to Predict Hepatocellular Carcinoma.
Clin Gastroenterol Hepatol
; 22(3): 602-610.e7, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37993034
10.
Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease.
Hepatology
; 77(2): 573-584, 2023 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35790018
11.
Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: A landmark analysis.
Hepatology
; 78(6): 1816-1827, 2023 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37119179
12.
Hippocampal sclerosis and temporal lobe epilepsy following febrile status epilepticus: The FEBSTAT study.
Epilepsia
; 2024 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38606600
13.
Organ-specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective study.
Liver Int
; 2024 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38618972
14.
Endothelial Senescence: A New Age in Pulmonary Hypertension.
Circ Res
; 130(6): 928-941, 2022 03 18.
Artigo
Inglês
| MEDLINE | ID: mdl-35298304
15.
Genome-wide detection of cytosine methylation by single molecule real-time sequencing.
Proc Natl Acad Sci U S A
; 118(5)2021 02 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33495335
16.
Isoformic PD-1-mediated immunosuppression underlies resistance to PD-1 blockade in hepatocellular carcinoma patients.
Gut
; 72(8): 1568-1580, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-36450387
17.
Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma.
Gut
; 72(9): 1758-1773, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37019619
18.
Detection and characterization of jagged ends of double-stranded DNA in plasma.
Genome Res
; 30(8): 1144-1153, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32801148
19.
Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study.
Breast Cancer Res Treat
; 199(1): 35-46, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36859649
20.
Baveno VII criteria identify varices needing treatment in patients with hepatocellular carcinoma of different Barcelona Clinic Liver Cancer stages.
J Gastroenterol Hepatol
; 38(8): 1381-1388, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37218373